# Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation

> **NCT03662477** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shenzhen Fifth People's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- NK Cell Mediated Immunity

## Interventions

- **BIOLOGICAL:** NK cells

## Key facts

- **NCT ID:** NCT03662477
- **Lead sponsor:** Shenzhen Fifth People's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-12-20
- **Final completion:** 2021-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2019-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03662477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03662477, "Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03662477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*